TY  - JOUR
PY  - 2023//
TI  - A review of psilocybin: chemistry, clinical uses and future research directions
JO  - Australian journal of chemistry
A1  - Milliken, Eliza
A1  - Galettis, Peter
A1  - Martin, Jenny
A1  - Milliken, Eliza
A1  - Galettis, Peter
A1  - Martin, Jenny
SP  - 258
EP  - 263
VL  - 76
IS  - 5
N2  - Classic psychedelics such as psilocybin, ketamine and lysergic acid diethylamide (LSD) are 5HT2A serotonin receptor agonists that produce individualised subjective affects. Today, public interest in psychedelic medicine has reached a fervour but the evidence for clinical benefit still lags. Psilocybin and psilocin are tryptophan based alkaloids found worldwide in mushrooms of the genera Psilocybe, Panaeolus, Conocybe, Gymnopilus, Stropharia, Pluteus and Panaeolina. This review addresses the current evidence base for psilocybin as a clinical medicine, the general chemistry and proposed mechanism of its therapeutic effect and future research directions for psilocybin based therapies.<p />  <p>Language: en</p>
LA  - en
SN  - 0004-9425
UR  - http://dx.doi.org/10.1071/CH23010
ID  - ref1
ER  -